Mineralization and the Role of Matrixphosphoglycoprotein
Mineralization and the Role of Matrixphosphoglycoprotein
批准号:
6886706
负责人:
PETER S ROWE
金额:
$4.67万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2005-07-31
关键词:
boneclinical researchextracellular matrix proteinsglycoproteinshuman tissuelaboratory mouselaboratory ratmetalloendopeptidasesnormal ossificationodontoblastsosteoblastspathologic ossificationpathologic processpeptidesphosphoproteinsprotein protein interactionprotein quantitation /detectionprotein sequenceprotein structureprotein structure functiontoothvitamin D resistant rickets
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): X-linked hypophosphatemic rickets (HYP) is associated with severe defects in renal phosphate handling, vitamin D metabolism and mineralization. Understanding the pathophysiology of bone-mineral/renal loss disorders is prerequisite to effective treatment of HYP, periodontal disease, tumor induced osteomalacia, renal-stones, osteoporosis, ectopic-calcifications and renal dysfunction. We have substantive preliminary data that supports the hypothesis that mineralization in teeth and bone is regulated by a protein-protein interaction between MEPE (a matrix extracellular phosphoglycoprotein markedly elevated in HYP) and PHEX (a Zn-metalloendopeptidase defective in HYP). The MEPE-PHEX protein-protein interaction protects MEPE from proteolytic cleavage by proteases markedly elevated in HYP (notably cathepsin B). Osteoblast and odontoblast secreted-MEPE in the absence of PHEX is proteolytically cleaved, releasing a phosphorylated, acidic-aspartate-serine-rich, COOH-terminal MEPE-fragment (ASARM-peptide). The ASARM-peptide (2 kDa) is remarkably resistant to a vast array of proteases resulting in increased levels in Hyp. The ASARM-peptide inhibits mineralization and is a negative modulator of normal mineralization and elevated ASARM-peptide is wholly or in part responsible for the mineralization defects in HYP. This proposal will specifically focus on the role of MEPE and ASARM-peptides in mineralization in disease and health. Our specific aims will be: 1. Structural characterization and quantification of MEPE ASARM-peptide(s) in-vitro and in-vivo in normal and Hyp-mouse osteoblasts and HYP patient-serum. 2. Determination of MEPE ASARM-peptide effects on mineralization in-vitro and in-vivo (rats). The ASARM-motif is present in a number of tooth-bone matrix and salivary proteins (MEPE, dentin-matrix-protein-1, osteopontin, statherin, dentin-sialo-phosphoprotein, etc.) that all map to chromosome 4q21. Thus, the elucidation of its role in mineralization is of prime importance for understanding tooth and bone development. Importantly, the part the motif plays in the multiple functions of MEPE will have relevance to the treatment and understanding of periodontal disease, oncogenic hypophosphatemic osteomalacia (OHO), HYP, osteoporosis and disorders of mineralization in teeth, bone, renal-stones and arteries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Molecular Pathology and Etiology of Nephrogenic Systemic Fibrosis
-
批准号:9384115
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2017
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:6830580
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:8289459
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization and the Role of Matrixphosphoglycoprotein
-
批准号:6789566
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization and the Role of Matrixphosphoglycoprotein
-
批准号:7150740
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:7146933
-
项目类别:
-
资助金额:$14.29万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:7736587
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:8097964
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:6947829
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:7088784
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:7886611
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:7257306
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
Mineralization of the matrix in disease and health
-
批准号:8493778
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2004
-
负责人:PETER S ROWE
-
依托单位:
TRIAL OF FLUDROCORTISONE FOR CHRONIC FATIGUE SYNDROME
-
批准号:6114290
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:PETER S ROWE
-
依托单位:
TRIAL OF FLUDROCORTISONE FOR CHRONIC FATIGUE SYNDROME
-
批准号:6245434
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1997
-
负责人:PETER S ROWE
-
依托单位:
TRIAL OF FLUDROCORTISONE FOR CHRONIC FATIGUE SYNDROME
-
批准号:6275525
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:PETER S ROWE
-
依托单位:
海外基金